BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22786830)

  • 21. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA; Blake JM; Crosignani PG
    Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force.
    Nelson HD; Haney EM; Dana T; Bougatsos C; Chou R
    Ann Intern Med; 2010 Jul; 153(2):99-111. PubMed ID: 20621892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar C; Marjoribanks J; Lethaby A; Suckling JA; Lamberts Q
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004143. PubMed ID: 19370593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menopausal hormone therapy.
    Bhavnani BR; Strickler RC
    J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
    PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rise and fall of menopausal hormone therapy.
    Barrett-Connor E; Grady D; Stefanick ML
    Annu Rev Public Health; 2005; 26():115-40. PubMed ID: 15760283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal Hormone Therapy and Mortality: A Systematic Review and Meta-Analysis.
    Benkhadra K; Mohammed K; Al Nofal A; Carranza Leon BG; Alahdab F; Faubion S; Montori VM; Abu Dabrh AM; Zúñiga Hernández JA; Prokop LJ; Murad MH
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4021-8. PubMed ID: 26544652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.
    Langer RD; Simon JA; Pines A; Lobo RA; Hodis HN; Pickar JH; Archer DF; Sarrel PM; Utian WH
    Climacteric; 2017 Oct; 20(5):402-413. PubMed ID: 28805475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.
    Roth JA; Etzioni R; Waters TM; Pettinger M; Rossouw JE; Anderson GL; Chlebowski RT; Manson JE; Hlatky M; Johnson KC; Ramsey SD
    Ann Intern Med; 2014 May; 160(9):594-602. PubMed ID: 24798522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.
    Guirguis-Blake JM; Evans CV; Senger CA; O'Connor EA; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):804-13. PubMed ID: 27064410
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.